Results 71 to 80 of about 1,721 (143)

Different Effect of Dienogest on Endometrium Mesenchymal Stem Cells Derived from Healthy and Endometriosis Tissues

Balkan Medical Journal
Background: Endometriosis (EM) is an inflammatory condition in which the endometrium is observed to develop outside the uterine cavity. Endometrium has conventionally been recognized as a rich source of endometrial mesenchymal stem cells (E-MSCs).
Hayal Uzelli Şimşek, Turgay Şimşek, Gökhan Duruksu, Selenay Furat Rençber, Yusufhan Yazır   +4 more
doaj   +1 more source

A Comparative Study of Dienogest Versus Medroxyprogesterone Acetate in Endometriosis- Associated Dysmenorrhea and Menstrual Irregularities: A Randomized Trial

JK Science
Background: Endometriosis is a chronic gynecologic disease that is dependent on estrogen and is associated with the existence of endometrial glands and stroma outside the uterus.
Amiya, Jyoti Kaushal, Savita Rani Singhal   +2 more
doaj  

ELIMINATION OF CHRONIC PELVIC PAIN CAUSED BY ADENOMYOSIS THE PROGESTOGENS NEW GENERATION

Акушерство, гинекология и репродукция, 2016
Endometriosis, with more than centenary history, remains a challenge in our day. One of the more common options is adenomyosis, the share of which amounts to 80%.
M. R. Orazov, A. V. Chayka, E. N. Nosenko   +2 more
doaj  

Efficacy and acceptability of dienogest among patients with endometriosis in Thailand. [PDF]

BMC Womens Health
Suwan A, Rungruxsirivorn T, Panyakhamlerd K, Apirakviriya C, Chavaengkiat S, Regidor PA.   +5 more
europepmc   +1 more source

Effect of extended hormonal suppression in patients with adenomyosis undergoing embryo transfer. [PDF]

Front Reprod Health
Etrusco A, Maiorana A, Roncarati I, Cozzolino M.   +3 more
europepmc   +1 more source

The inhibition of deep peritoneal endometriosis by Andrographolide through macrophage M1 activity in an endometriosis mice model. [PDF]

Vet Med (Praha)
Susianto IA, Susilaningsih N, Hidayat ST, Hardian, Tjandrawinata RR, Rachmawati B.   +5 more
europepmc   +1 more source

Fertility preservation in women with endometriosis: How, when, and for whom? [PDF]

J Int Med Res
Kalaitzopoulos DR, Kohl Schwartz AS.
europepmc   +1 more source

Correction to: Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial. [PDF]

Adv Ther
Kikuno K, Asada R, Ishihara T, Morishige KI, Chikazawa K, Furui T, Isobe M.   +6 more
europepmc   +1 more source

Differences in response to dienogest therapy among different phenotypes of endometriosis: A single-center retrospective cohort analysis. [PDF]

Medicine (Baltimore)
Liu J, Wu D, Sun J.
europepmc   +1 more source

Borderline ovarian clear cell tumor arising from endometriosis during long-term dienogest therapy: a case report. [PDF]

Front Oncol
Shang K, Xing H, Zhang S, Zhang Y, Zhang H.   +4 more
europepmc   +1 more source